KalVista Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
The current KalVista Pharmaceuticals(KALV) stock price is $13.62, with a market capitalization of 688.44M. The stock trades at a price-to-earnings (P/E) ratio of -3.41.
On 2025-11-16, KalVista Pharmaceuticals(KALV) stock moved within a range of $12.95 to $13.87. With shares now at $13.62, the stock is trading +5.2% above its intraday low and -1.8% below the session's peak.
Trading activity shows a volume of 1.33M, compared to an average daily volume of 1.41M.
The stock's 52-week range extends from a low of $7.30 to a high of $17.28.
The stock's 52-week range extends from a low of $7.30 to a high of $17.28.
KALV News
KalVista Pharmaceuticals, Inc. ( (KALV) ) has released its Q3 earnings. Here is a breakdown of the information KalVista Pharmaceuticals, Inc. presented to its i...